Sight Sciences, Inc. (NASDAQ: SGHT) is an eyecare technology company focused on creating innovative solutions to transform care and improve patients' lives, especially in glaucoma and dry eye. Sight Sciences, Inc. (NASDAQ: SGHT) Market Cap: $425.97M; Current Share Price: $8.79 Data by YCharts The Company and its Products Sight Sciences...
RxSight, Inc. (NASDAQ: RXST) is a commercial-stage ophthalmic medical device company that provides high-quality customized vision to patients following cataract surgery. The Company and its Products The Company is known for its RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light...
The American Academy of Ophthalmology defines cataract as the clouding of the lens through which light rays are refracted and is characterized by blurry or unclear vision, double images, sensitivity to light, difficulty in seeing well at night and seeing dull or faded color instead...
Kala Pharmaceuticals (NASDAQ: KALA) received a Complete Response Letter (CRL) from the FDA, asking for efficacy data from an additional trial, in response to its NDA for KPI-121 0.25%, its lead candidate for the treatment of dry eye disease. The company had filed a New...
Dry Eye Syndrome is characterized by the inability to produce sufficient amount or quality of tears which leads to lack of lubrication and nourishment to the surface of the eye and manifests as chronic eye irritation, inflammation and damage to the surface. There are over...
